160 related articles for article (PubMed ID: 8260714)
21. Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.
Voogt PJ; Goulmy E; Fibbe WE; Veenhof WF; Brand A; Falkenburg JH
J Clin Invest; 1988 Sep; 82(3):906-12. PubMed ID: 3262125
[TBL] [Abstract][Full Text] [Related]
22. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
23. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.
Faber LM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Exp Med; 1992 Nov; 176(5):1283-9. PubMed ID: 1402674
[TBL] [Abstract][Full Text] [Related]
24. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
Blood; 1993 Apr; 81(8):2200-8. PubMed ID: 8471780
[TBL] [Abstract][Full Text] [Related]
25. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
Vogt MH; van den Muijsenberg JW; Goulmy E; Spierings E; Kluck P; Kester MG; van Soest RA; Drijfhout JW; Willemze R; Falkenburg JH
Blood; 2002 Apr; 99(8):3027-32. PubMed ID: 11929796
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
[TBL] [Abstract][Full Text] [Related]
27. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.
Voogt PJ; Fibbe WE; Marijt WA; Goulmy E; Veenhof WF; Hamilton M; Brand A; Zwann FE; Willemze R; van Rood JJ
Lancet; 1990 Jan; 335(8682):131-4. PubMed ID: 1967432
[TBL] [Abstract][Full Text] [Related]
28. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
Mutis T; Ghoreschi K; Schrama E; Kamp J; Heemskerk M; Falkenburg JH; Wilke M; Goulmy E
Biol Blood Marrow Transplant; 2002; 8(8):412-9. PubMed ID: 12234166
[TBL] [Abstract][Full Text] [Related]
29. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.
Gillespie G; Mutis T; Schrama E; Kamp J; Esendam B; Falkenburg JF; Goulmy E; Moss P
Hematol J; 2000; 1(6):403-10. PubMed ID: 11920221
[TBL] [Abstract][Full Text] [Related]
30. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
Nevala WK; Paul C; Wettstein PJ
Transplantation; 1998 Feb; 65(4):559-69. PubMed ID: 9500633
[TBL] [Abstract][Full Text] [Related]
31. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
[TBL] [Abstract][Full Text] [Related]
32. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.
Sugimoto K; Murata M; Terakura S; Naoe T
J Immunol; 2009 Nov; 183(9):5991-8. PubMed ID: 19812210
[TBL] [Abstract][Full Text] [Related]
33. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
34. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
[TBL] [Abstract][Full Text] [Related]
35. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
[TBL] [Abstract][Full Text] [Related]
36. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
Dickinson AM; Wang XN; Sviland L; Vyth-Dreese FA; Jackson GH; Schumacher TN; Haanen JB; Mutis T; Goulmy E
Nat Med; 2002 Apr; 8(4):410-4. PubMed ID: 11927949
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C
J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996
[TBL] [Abstract][Full Text] [Related]
38. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.
Rufer N; Wolpert E; Helg C; Tiercy JM; Gratwohl A; Chapuis B; Jeannet M; Goulmy E; Roosnek E
Transplantation; 1998 Oct; 66(7):910-6. PubMed ID: 9798702
[TBL] [Abstract][Full Text] [Related]
39. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
Georges GE; Lesnikova M; Storb R; Yunusov M; Little MT; Nash RA
Biol Blood Marrow Transplant; 2003 Apr; 9(4):234-42. PubMed ID: 12720216
[TBL] [Abstract][Full Text] [Related]
40. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection.
Vogt MH; de Paus RA; Voogt PJ; Willemze R; Falkenburg JH
Blood; 2000 Feb; 95(3):1100-5. PubMed ID: 10648428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]